Hypercrosslinked poly(AN-co-EGDMA-co-VBC): synthesis via suspension polymerization, characterizations, and potential to adsorb diclofenac and metformin from aqueous solution
Poly(acrylonitrile- co -ethylene glycol dimethacrylate- co -vinylbenzyl chloride) (poly(AN- co -EGDMA- co -VBC)) was synthesized by suspension polymerization and further hypercrosslinked by Friedel-Crafts reaction to serve as a sorbent to remove the pharmaceuticals. Energy dispersive X-ray analysis...
Gespeichert in:
Veröffentlicht in: | Colloid and polymer science 2020-12, Vol.298 (12), p.1649-1667 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Poly(acrylonitrile-
co
-ethylene glycol dimethacrylate-
co
-vinylbenzyl chloride) (poly(AN-
co
-EGDMA-
co
-VBC)) was synthesized by suspension polymerization and further hypercrosslinked by Friedel-Crafts reaction to serve as a sorbent to remove the pharmaceuticals. Energy dispersive X-ray analysis showed decreased chlorine content in the polymers, confirming a successful hypercrosslinking. BET analysis revealed that the hypercrosslinked (HXL) poly(AN-
co
-EGDMA-
co
-VBC) had a specific surface area up to 363 m
2
g
−1
with an average particle size of 77.2–174.1 μm. Hypercrosslinking of the polymer increased the specific surface area up to 42%, even at low VBC content (10%). Pore size distribution showed that the terpolymers were mesoporous. The maximum adsorption capacity of diclofenac (DCF) and metformin (MET) determined by the Langmuir isotherm model were up to 61.0 mg g
−1
and 5.1 mg g
−1
, respectively and the adsorption kinetic followed pseudo-second-order rate equation. The equilibrium capacity of the sorbent decreased to approximately 78% for DCF and 72% for MET after four cycles of adsorption-desorption process, exhibiting good reusability property.
Graphical abstract |
---|---|
ISSN: | 0303-402X 1435-1536 |
DOI: | 10.1007/s00396-020-04757-7 |